Список проголосовавших за комментарий " <table class="BriefingDataTable" border="0" cellspacing="0" cellpadding="0"><tr> <td class="tickerColumn"> </td> <td class="articleColumn">On The Wires<ul><li>ESSA Pharma (<strong>EPIX</strong>) receives $4 mln payment from the Cancer Prevention Research Institute of Texas. The payment is part of a total non-dilutive grant of $12.0 million, repayable out of potential product revenues, which was originally awarded in February 29, 2014. The payment recognizes eligible expenditures made by ESSA in conducting the Phase 1 dose escalation trial currently underway, and also costs incurred in preparation for the Phase 2 dose expansion clinical study expected to begin later this year.</li><li>Independence Holding Company (<strong>IHC</strong>) announced that it repurchased 290,000 shares of its common stock for $5.8 million in a private transaction.</li><li>According to Dr. Robert Hariri, U.S. Chairman of MYOS RENS Technology Inc. (<strong>MYOS</strong>) speaking recently on the importance of muscle health: «It is becoming increasingly apparent that muscle is a master regulatory tissue which is critical to metabolic and physiologic stability. In fact, building and maintaining lean muscle mass is one of the most important and actionable aspects of preserving overall health and wellness.»</li><li>'An experienced management group' led by Joseph M. Limber, in partnership with Ampersand Capital Partners and 1315 Capital, has entered into a definitive agreement to acquire the commercial laboratory of Genoptix, Inc., a Novartis (<strong>NVS</strong>) company that specializes in oncology diagnostics and informatics services. This transaction is expected to close in the first quarter of 2017 subject to certain closing conditions. The financial terms of the transaction are not being disclosed.</li><li>Syros Pharmaceuticals (<strong>SYRS</strong>) announced the appointment of Peter Wirth as Chair of its Board. Wirth was a senior executive at Genzyme from 1996 until its acquisition by Sanofi in 2011, most recently serving as EVP, Legal and Corporate Development, Chief Risk Officer and Corporate Secretary.</li><li>Wipro (<strong>WIT</strong>) announced a strategic partnership with Tradeshift to offer cloud-based Source-to-Pay Business Process as a Service solution.</li></ul></td> </tr></table>"